Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2021-12-03 Ownership | 2021-12-13 4:26 pm | N/A N/A | Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M 10% Owner | 0 | $0 | 18,631,771 (Indirect) | View |
2019-10-07 Conversion | 2019-10-09 6:23 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. PARMAR KUSH 10% Owner | 2,506,650 | $0 | 333,333 (Indirect) | View |
2019-10-02 Ownership | 2019-10-02 7:31 pm | N/A N/A | Aprea Therapeutics Inc. | APRE | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC DIEKMAN JOHN D Schwab Andrew J. 10% Owner | 0 | $0 | 2,519,320 (Indirect) | View |
2019-05-28 Conversion | 2019-05-28 8:40 pm | N/A N/A | IDEAYA Biosciences Inc. | IDYA | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 2,396,191 | $0 | 500,000 (Indirect) | View |
2019-05-22 Ownership | 2019-05-23 12:21 pm | N/A N/A | IDEAYA Biosciences Inc. | IDYA | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 0 | $0 | 2,713,066 (Indirect) | View |
2019-02-20 Other | 2019-02-22 8:06 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner | 477,363 | $0 | 486,292 (Indirect) | View |
2018-07-20 Conversion | 2018-07-20 7:02 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner | 14,518,556 | $0 | 139,969 (Indirect) | View |
2018-07-17 Ownership | 2018-07-17 8:14 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner | 0 | $0 | 3,384,278 (Indirect) | View |
2018-04-02 Conversion | 2018-04-04 6:41 pm | N/A N/A | Homology Medicines Inc. | FIXX | 5AM Ventures IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 5AM Co-Investors IV L.P. 10% Owner | 10,784,074 | $0 | 6,722,076 (Indirect) | View |
2018-03-27 Ownership | 2018-03-27 8:47 pm | N/A N/A | Homology Medicines Inc. | FIXX | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC ROCKLAGE SCOTT M DIEKMAN JOHN D Schwab Andrew J. 10% Owner | 0 | $0 | 6,722,076 (Indirect) | View |
2017-11-21 Conversion | 2017-11-21 7:16 pm | N/A N/A | scPharmaceuticals Inc. | SCPH | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. Schwab Andrew J. DIEKMAN JOHN D ROCKLAGE SCOTT M 10% Owner | 21,257,687 | $0 | 130,135 (Indirect) | View |
2017-11-16 Ownership | 2017-11-16 9:15 pm | N/A N/A | scPharmaceuticals Inc. | SCPH | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. Schwab Andrew J. DIEKMAN JOHN D ROCKLAGE SCOTT M 10% Owner | 0 | $0 | 18,659,012 (Indirect) | View |